Summary

Bilirubin Testing Market Summary

The global bilirubin testing market size was estimated at USD 2.16 billion in 2025 and is projected to reach USD 2.94 billion by 2033, growing at a CAGR of 4.04% from 2026 to 2033. The market is experiencing a transformative phase, driven by an urgent need for early diagnostic tools in neonatal care and the rising prevalence of liver-related diseases.

Recently, there is a significant pivot toward point-of-care (POC) testing, with new microfluidic devices achieving over 90% sensitivity in clinical trials. These innovations are largely propelled by the increasing incidence of neonatal jaundice, which affects nearly 60% of full-term infants, and the global surge in chronic liver conditions such as Nonalcoholic Fatty Liver Disease (NAFLD).

Strategic moves by industry leaders, including the integration of automated high-throughput analyzers in diagnostic labs, are streamlining workflows and reducing the time-to-result from hours to minutes. This evolution is further supported by updated clinical guidelines from organizations like the American Academy of Pediatrics (AAP), which advocate for more rigorous screening protocols to prevent kernicterus, thereby cementing bilirubin testing as a non-negotiable standard in modern pediatric healthcare.

In July 2025, a pilot study reported the development of a new microfluidic-based point-of-care device for bilirubin testing that demonstrated strong correlation (R? = 0.986) with standard laboratory methods, along with high sensitivity (90%) and specificity (97%) in classifying clinically relevant bilirubin levels. Designed with portable optoelectronic sensing technology, the device aims to provide accurate, rapid testing outside traditional laboratory settings, particularly benefiting neonatal jaundice screening and liver function assessment in decentralized or resource-limited environments. Although validated on a small sample size and requiring broader clinical studies, the innovation supports the expansion of point-of-care diagnostics, increases accessibility to bilirubin testing, and is likely to drive growth in the decentralized and neonatal diagnostics segments of the market.

One of the most significant developments in the market scope is the rapid adoption of transcutaneous bilirubinometry (TcB) and smartphone-based diagnostic applications. Traditionally, bilirubin levels were measured via invasive "heel stick" blood draws, which cause significant distress to neonates and carry risks of infection. However, the market is now shifting toward light-based, non-invasive sensors that provide instantaneous readings through the skin. Emerging research into Artificial Intelligence (AI) and machine learning has introduced 1D Convolutional Neural Networks capable of analyzing smartphone images of an infant's skin or eyes to predict bilirubin levels with near-clinical accuracy. This technological leap not only enhances patient comfort but also expands the market’s reach into home-based monitoring and remote healthcare settings, allowing parents and clinicians to track jaundice levels without frequent hospital visits.

Global Bilirubin Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bilirubin testing market report based on product, technology, application, patient, end use, and region:

? Product Outlook (Revenue, USD Million, 2021 - 2033)
? Bilirubin Reagent Kits and Assay Consumables
? Calibrators and Quality Controls
? Test Cartridges and Strips
? Dedicated Blood Bilirubin Analyzers
? Technology Outlook (Revenue, USD Million, 2021 - 2033)
? Laboratory-Based Testing
? POC Testing
? Application Outlook (Revenue, USD Million, 2021 - 2033)
? Neonatal Jaundice Screening and Monitoring
? Liver Function Testing (LFT)
? Hemolytic Disorders Assessment
? Routine & Pre-operative Health Screening
? Patient Outlook (Revenue, USD Million, 2021 - 2033)
? Neonates
? Pediatric Patients
? Adults
? End Use Outlook (Revenue, USD Million, 2021 - 2033)
? Hospitals & NICUs
? Diagnostic Laboratories
? Maternity and Neonatal Clinics
? Others
? Regional Outlook (Revenue, USD Million, 2021 - 2033)
? North America
o U.S.
o Canada
o Mexico
? Europe
o UK
o Germany
o France
o Spain
o Italy
o Denmark
o Sweden
o Norway
? Asia Pacific
o Japan
o China
o India
o South Korea
o Australia
o Thailand
? Latin America
o Brazil
o Argentina
? Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Patients
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Bilirubin Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing prevalence of neonatal jaundice and liver disorders
3.2.1.2. Rising adoption of point-of-care and decentralized diagnostic solutions
3.2.1.3. Continuous technological advancements improving accuracy and turnaround time
3.2.2. Market Restraints Analysis
3.2.2.1. Presence of Ambiguous Regulatory Framework
3.2.2.2. Limited reimbursement support
3.2.3. Market Opportunity Analysis
3.2.4. Supply Chain Analysis
3.3. Bilirubin Testing Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Pricing Analysis
Chapter 4. Bilirubin Testing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bilirubin Testing Market: Product Movement Analysis, USD Million, 2025 & 2033
4.3. Bilirubin Reagent Kits and Assay Consumables
4.3.1. Bilirubin Reagent Kits and Assay Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Calibrators and Quality Controls
4.4.1. Calibrators and Quality Controls Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Test Cartridges and Strips
4.5.1. Test Cartridges and Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Dedicated Blood Bilirubin Analyzers
4.6.1. Dedicated Blood Bilirubin Analyzers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Bilirubin Testing Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Bilirubin Testing Market: Testing Movement Analysis, USD Million, 2025 & 2033
5.3. Laboratories-Based Testing
5.3.1. Laboratories-Based Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. POC Testing
5.4.1. POC Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Bilirubin Testing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Bilirubin Testing Market: Application Movement Analysis, USD Million, 2025 & 2033
6.3. Neonatal Jaundice Screening and Monitoring
6.3.1. Neonatal Jaundice Screening and Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Liver Function Testing (LFT)
6.4.1. Liver Function Testing (LFT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Hemolytic Disorders Assessment/Cancer
6.5.1. Hemolytic Disorders Assessment/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Routine & Pre-operative Health Screening
6.6.1. Routine & Pre-operative Health Screening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Bilirubin Testing Market: Patients Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Bilirubin Testing Market: Patients Movement Analysis, USD Million, 2025 & 2033
7.3. Neonates
7.3.1. Neonates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Pediatric Patients
7.4.1. Pediatric Patients Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Adults
7.5.1. Adults Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Bilirubin Testing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Bilirubin Testing Market: End Use Movement Analysis, USD Million, 2025 & 2033
8.3. Hospitals & NICUs
8.3.1. Hospitals & NICUs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Diagnostic Laboratories
8.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Maternity and Neonatal Clinics
8.5.1. Maternity and Neonatal Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Bilirubin Testing Market: Regional Estimates & Trend Analysis
9.1. Bilirubin Testing Market Share, By Region, 2025 & 2033, USD Million
9.2. North America
9.2.1. North America Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Regulatory Landscape/Reimbursement Scenario
9.2.4.3. Competitive Insights
9.2.4.4. Mexico Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3. Europe
9.3.1. Europe Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. UK Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.7. Sweden
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Sweden Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Denmark Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.2. China
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. China Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. Japan Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. South Korea Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Australia Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. Thailand Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Latin America
9.5.1. Latin America Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Argentina Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. Saudi Arabia Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.3. UAE
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. UAE Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.4. South Africa
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. South Africa Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait Bilirubin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Global Company Market Share Analysis, 2025
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. Abbott
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Beckman Coulter, Inc.
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Siemens Healthineers AG
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. Randox Laboratories Ltd.
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. SEKISUI Diagnostics
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. Fortress Diagnostics
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Quidel Corporation
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. Agappe Diagnostics Ltd.
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Nova Biomedical
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Radiometer Medical ApS
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Bilirubin Testing Market, By Region, 2021 - 2033 (USD Million)
Table 5 Global Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 6 Global Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 7 Global Bilirubin Testing Market, By Application, 2021 - 2033 USD Million
Table 8 Global Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 9 Global Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 10 North America Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
Table 11 North America Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 12 North America Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 13 North America Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 14 North America Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 15 North America Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 16 U.S. Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 17 U.S. Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 18 U.S. Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 19 U.S. Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 20 U.S. Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 21 Canada Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 22 Canada Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 23 Canada Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 24 Canada Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 25 Canada Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 26 Mexico Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 27 Mexico Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 28 Mexico Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 29 Mexico Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 30 Mexico Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 31 Europe Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
Table 32 Europe Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 33 Europe Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 34 Europe Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 35 Europe Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 36 Europe Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 37 UK Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 38 UK Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 39 UK Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 40 UK Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 41 UK Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 42 Germany Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 43 Germany Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 44 Germany Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 45 Germany America Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 46 Germany Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 47 France Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 48 France Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 49 France Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 50 France Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 51 France Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 52 Spain Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 53 Spain Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 54 Spain Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 55 Spain Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 56 Spain Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 57 Italy Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 58 Italy Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 59 Italy Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 60 Italy Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 61 Italy Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 64 Asia Pacific Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 65 Asia Pacific Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 66 Asia-Pacific Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 67 Asia-Pacific Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 68 China Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 69 China Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 70 China Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 71 China Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 72 China Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 73 Japan Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 74 Japan Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 75 Japan Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 76 Japan Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 77 Japan Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 78 India Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 79 India Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 80 India Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 81 India Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 82 India Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 83 South Korea Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 84 South Korea Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 85 South Korea Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 86 South Korea Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 87 South Korea Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 88 Australia Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 89 Australia Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 90 Australia Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 91 Australia Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 92 Australia Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 93 Latin America Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
Table 94 Latin America Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 95 Latin America Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 96 Latin America Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 97 Latin America Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 98 Latin America Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 99 Brazil Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 100 Brazil Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 101 Brazil Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 102 Brazil Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 103 Brazil Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 104 Argentina Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 105 Argentina Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 106 Argentina Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 107 Argentina Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 108 Argentina Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 109 MEA Bilirubin Testing Market, By Country, 2021 - 2033 (USD Million)
Table 110 MEA Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 111 MEA Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 112 MEA Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 113 MEA Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 114 MEA Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 115 South Africa Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 116 South Africa Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 117 South Africa Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 118 South Africa Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 119 UAE Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 120 UAE Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 121 UAE Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 122 UAE Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 123 UAE Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 124 UAE Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million) Million
Table 125 Saudi Arabia Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 126 Saudi Arabia Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 127 Saudi Arabia Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 128 Saudi Arabia Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 129 Saudi Arabia Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)
Table 130 Kuwait Bilirubin Testing Market, By Product, 2021 - 2033 (USD Million)
Table 131 Kuwait Bilirubin Testing Market, By Testing, 2021 - 2033 (USD Million)
Table 132 Kuwait Bilirubin Testing Market, By Application, 2021 - 2033 (USD Million)
Table 133 Kuwait Bilirubin Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 134 Kuwait Bilirubin Testing Market, By Patients, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Bilirubin Testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 In vitro diagnostic market snapshot
Fig. 10 Parent market outlook, 2025
Fig. 11 In vitro diagnostic market driver impact
Fig. 12 Global elderly population
Fig. 13 New cancer cases by year
Fig. 14 In vitro diagnostic market restraint impact
Fig. 15 Market entry strategy
Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 Bilirubin testing market: Product outlook and key takeaways
Fig. 19 Bilirubin testing market: Products movement analysis
Fig. 20 Bilirubin Reagent Kits and Assay Consumables market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 21 Calibrators and Quality Controls market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 22 Test Cartridges and Strips market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 23 Dedicated Blood Bilirubin Analyzers market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 24 Bilirubin testing market: Technology outlook and key takeaways
Fig. 25 Bilirubin Testing: Technology movement analysis
Fig. 26 Laboratories-Based Testing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 27 POC Testing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 28 Bilirubin testing market: Application outlook and key takeaways
Fig. 29 Bilirubin testing market: Application movement analysis
Fig. 30 Neonatal Jaundice Screening and Monitoring market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 31 Liver Function Testing (LFT) market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 32 Hemolytic Disorders Assessment market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 33 Routine & Pre-operative Health Screening market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 34 Bilirubin testing market: End Use outlook and key takeaways
Fig. 35 Bilirubin testing market: End Use movement analysis
Fig. 36 Hospitals & NICUs market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 37 Diagnostic Laboratories market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 38 Home care market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 39 Other market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 40 Bilirubin testing market: test location outlook and key takeaways
Fig. 41 IVD treatment market: Test location movement analysis
Fig. 42 Point-of-care market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 43 Homecare market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 44 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 45 Bilirubin Testing: Regional outlook and key takeaways
Fig. 46 Bilirubin testing market: Regional movement analysis
Fig. 47 North America
Fig. 48 North America. market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 49 U.S. key country dynamics
Fig. 50 U.S. market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 51 Canada key country dynamics
Fig. 52 Canada market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 53 Mexico key country dynamics
Fig. 54 Mexico market estimates and forecast, 2021 - 2033 (USD Million),
Fig. 55 Europe
Fig. 56 Europe market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 57 UK key country dynamics
Fig. 58 UK market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 59 Germany key country dynamics
Fig. 60 Germany market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 61 Spain key country dynamics
Fig. 62 Spain market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 63 France key country dynamics
Fig. 64 France market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 65 Italy key country dynamics
Fig. 66 Italy market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 67 Denmark key country dynamics
Fig. 68 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 69 Sweden key country dynamics
Fig. 70 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 71 Norway key country dynamics
Fig. 72 Norway market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 73 Asia Pacific
Fig. 74 Asia Pacific market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 75 Japan key country dynamics
Fig. 76 Japan market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 77 China key country dynamics
Fig. 78 China. market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 79 India key country dynamics
Fig. 80 India. market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 81 South Korea key country dynamics
Fig. 82 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 83 Thailand key country dynamics
Fig. 84 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 85 Australia key country dynamics
Fig. 86 Australia market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 87 Latin America
Fig. 88 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 89 Brazil key country dynamics
Fig. 90 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 91 Argentina key country dynamics
Fig. 92 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 93 MEA
Fig. 94 MEA market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 95 South Africa key country dynamics
Fig. 96 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 97 UAE key country dynamics
Fig. 98 UAE market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 99 Saudi Arabia key country dynamics
Fig. 100 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 101 Kuwait key country dynamics
Fig. 102 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)